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Antibiotics from Streptomyces coelicolor
tion in hand and utilizing increasingly powerful genetic
tools for the manipulation of microbial secondary me-
tabolite genes, it should be possible to reprogram the
biosynthesis of natural products in order to produce new
molecules with altered and possibly improved biological
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of last resort, vancomycin. While there is always a need
for new improved therapeutics of all kinds, the increase
in the incidence of pathogenic bacteria with resistanceSummary
to known antibiotics means that there has never been
a greater need for new antimicrobial agents.The calcium-dependent antibiotic (CDA), from Strep-
tomyces coelicolor, is an acidic lipopeptide comprising Recently, an 82 kb region of the Streptomyces coeli-
color A3(2) genome that encodes the biosynthetican N-terminal 2,3-epoxyhexanoyl fatty acid side chain
and several nonproteinogenic amino acid residues. S. enzymes required for the production of the calcium-
dependent antibiotic (CDA), an acidic lipopeptide, wascoelicolor grown on solid media was shown to produce
several previously uncharacterized peptides with C-ter- identified, cloned, and partially sequenced at UMIST [8].
The CDA gene cluster, which comprises approximatelyminal Z-dehydrotryptophan residues. The CDA bio-
synthetic gene cluster contains open reading frames 1% of the genome, was subsequently sequenced in
entirety as part of the S. coelicolor genome project [1].encoding nonribosomal peptide synthetases, fatty
acid synthases, and enzymes involved in precursor CDA is a cyclic-lactone undecapeptide which, in addi-
tion to an N-terminal 2,3-epoxyhexanoyl side chain, con-supply and tailoring of the nascent peptide. On the
basis of protein sequence similarity and chemical rea- tains several D-configured as well as nonproteinogenic
amino acids, including D-4-hydroxyphenylglycine, D-3-soning, the biosynthesis of CDA is rationalized. Dele-
tion of SCO3229 (hmaS), a putative 4-hydroxymandelic phosphohydroxyasparagine, and L-3-methylglutamic
acid [9] (Figure 1).acid synthase-encoding gene, abolishes CDA produc-
tion. The exogenous supply of 4-hydroxymandelate, CDA shares a similar structure and possibly a related
mode of action to other acidic lipopeptide antibiotics,4-hydroxyphenylglyoxylate, or 4-hydroxyphenylgly-
cine re-establishes CDA production by the hmaS including daptomycin [10], friulimicins, and amphomyc-
ins [11] (Figure 1). Interestingly, all of these antibioticsmutant. Feeding analogs of these precursors to the
mutant resulted in the directed biosynthesis of novel are comprised of a decapeptide lactone or lactam ring
derived from cyclization of L-threonine or L-threo-2,3-lipopeptides with modified arylglycine residues.
diaminobutyrate side chains onto the C-terminal car-
boxyl group. Noticeably, six of the amino acid sideIntroduction
chains in the CDA lactone ring are found at the same
positions in the other lipopeptide structures, includingWith the advent of the post-genomic era, the sequences
several acidic residues which are likely to be importantof numerous gene clusters required for the biosynthesis
for calcium binding and biological activity. The thera-of many valuable secondary metabolites have become
peutic importance of this class of antibiotics is bestavailable for exploitation. Most notably, the genomes
exemplified by daptomycin, which is active against aof Streptomyces coelicolor A3(2) [1] and Streptomyces
wide range of gram-positive pathogens including strainsavermitilis [2] from the prolific secondary metabolite-
resistant to all current antibiotic treatments. At present,producing actinomycete genus have recently been se-
daptomycin, under the trade name Cidecin, is undergo-quenced. Each reveals more than 20 gene clusters pre-
ing phase III clinical trials for the treatment of a rangedicted to be involved in the biosynthesis of secondary
of life-threatening infections.metabolites. With this wealth of new sequence informa-
In this paper, the isolation and structural elucidation
of novel CDA lipopeptides from wild-type S. coelicolor5 Correspondence: jason.micklefield@umist.ac.uk (J.M.), colin.
smith@umist.ac.uk (C.P.S.) is described. A hypothesis, based on sequence analysis
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Figure 1. The Structures of Acidic Lipopeptide Antibiotics
(A) The calcium-dependent antibiotics isolated from S. coelicolor. The table shows the variability of amino acid residues at positions 6, 9, 10,
and 11. Common amino acid residues found at the same positions in other acidic lipopeptides are indicated with an asterisk. The b-series
CDA were isolated and characterized previously, and all were shown to possess a C-terminal L-tryptophan residue [9]. CDA2a and CDA4a
were isolated from strain 2377 grown on solid media in this study and shown to differ by the presence of a C-terminal Z-2,3-dehydrotryptophan
residue. aCDA3a was isolated previously, but not fully characterized [9]; bCDA2d, CDA2fa, and CDA2fb were isolated from the 2377hmaS
mutant supplemented with racemic phenylglycine or 4-fluorophenylglycine.
(B) Friulimicin B (X  NH2, R1  H, R2  CH3) and amphomycin A-1437B (X  OH, R1  CH3, R2  H) from Actinoplanes friuliensis [11].
(C) Daptomycin (LY146032) derived from A21978C produced by Streptomyces roseosporus [10].
of the gene products from the CDA cluster, is proposed CDAs (data not shown) to that described previously [9].
However, strain 2377, when grown on oxoid nutrientthat accounts for the biosynthesis of CDA. Finally, the
agar (ONA), was shown, by LC-MS of the exudate, tofirst rational engineered biosynthesis of novel modified
produce previously uncharacterized CDA2a (1574 Da)lipopetides of this class is demonstrated using a muta-
and CDA4a (1494 Da) as major products (Figure 1). Solid-synthesis approach.
phase extraction on the exudate from large-scale solid
media cultures followed by purification (HPLC) provided
Results and Discussion sufficient quantities of these peptides to allow detailed
structural elucidation.
Isolation and Characterization of Natural First, UV spectra of both CDA2a and CDA4a (see Sup-
CDA Variants plemental Data) reveal a major absorption max 349 nm
The structures of four calcium-dependent antibiotics, (in H2O) that is absent from previously characterized
CDA1b, 2b, 3b, and 4b (Figure 1), produced by S. coeli- (b-series) peptides (max 279 in H2O). This is indicative
color A3(2) 2377 were determined previously [9]. These of the presence of 2,3-dehydrotryptophan (Trp) [14,
structures differ in the substitution pattern at amino acid 15]. High-resolution electrospray ionization mass spec-
residue 9, which is either D-3-hydroxyasparagine or D- trometry (HRESIMS) of CDA2a (m/z 1575.4955 [MH],
3-phosphohydroxyasparagine, and residue 10, which is C67H80N14O29P requires 1575.4953) and CDA4a (m/z
either L-glutamic acid or L-3-methylglutamic acid. Minor 1495.5238 [MH], C67H79N14O26 requires 1495.5290) are
amounts of other peptides CDA3a and CDA4a, which consistent with the molecular formula for the structures
differ in molecular weight by 2 Da, were also isolated proposed. Both peptides are 2 Da lower than CDA2b
but had not been characterized to date. In order to and CDA4b, respectively, which implies that only one
determine the structure of these minor metabolites and of the tryptophan-derived residues, at either position 3
any other natural CDA variants, S. coelicolor strains 2377 or 11, has been dehydrogenated. In order to determine
[12] and MT1110 [13] were cultivated in a variety of the position of the Trp residue, the lower molecular
different media. LC-MS of supernatants from many dif- weight peptide CDA4a, which is nonphosphorylated,
was transformed to the corresponding n-propyl tetraam-ferent liquid culture media revealed a similar profile of
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Figure 2. MS-MS Sequencing of CDA4a De-
rivative
(A) The linear peptide derived from CDA4a by
tetramidation followed by basic hydrolysis,
showing fragmentation pattern observed in
the product ion MS-MS spectra (see Supple-
mental Data).
(B) The observed and calculated masses of
the Y″ and B-series ions resulting from the
product ion spectrum of the linear peptide
derived from CDA4a. Accurate masses were
determined for the majority of ions; the re-
mainder were recorded at lower resolution.
All are in agreement with the elemental for-
mula derived from the predicted fragmenta-
tion pattern shown.
ide using 1-propylamine, TBTU, and HOBt [9]. The major were assigned using 1H-13C HMQC, HMBC, and 1H-1H
COSY experiments (see Table 1 in the Supplementalproduct of the reaction was purified by HPLC and shown
to possess the expected molecular formula by HRESIMS Data). The chemical shifts for the 2,3-epoxyhexanoyl
side chain and amino acid residues 1–10 are in close(m/z 1659.7734 [MH], C79H107N18O22 requires 1659.
7807). Hydrolysis of the peptide with 1 M aqueous NaOH agreement with those reported previously for CDA2b
[9]. However, typicaland chemical shifts for a secondand purification (RP-HPLC) gave a linear peptide (Figure
2A) of the same molecular formula (HRESIMS: m/z tryptophan residue are clearly absent. Instead, the 1H
and 13C signals were observed, which agree closely with1659.7792). The ESI MS-MS product ion spectra of this
peptide (see Supplemental Data) and accurate mass the chemical shifts for Trp residues in other cyclic
peptide natural products, including keramide F [14] andmeasurements of key Y″ and B series ions (Figure 2B)
were entirely consistent with the proposed structure of microsclerodermins G and I [16]. The stereochemistry
of theTrp residue in CDA2b is assigned Z configurationthe linear peptide. Notably, the B10 ion (m/z 1457.7017)
confirmed the presence of a C-terminal Trp (position on the basis of the chemical shift of the -proton (H 
8.00), which compares favorably with that observed for11). The other observed ions also confirmed the se-
quence of the peptide and indicated that opening of the (Z )-Trp containing keramide F (H  7.83) [14] and
N-acetyl-2,3-dehydrotryptophan ethyl ester [H  7.60lactone ring proceeds with concomitant transformation
of threonine, at position 2, to 2,3-dehydro-2-aminobu- (Z ) and 6.90 (E )] [15]. The relative stereochemistry of
the 2,3-epoxyhexanoyl side chain is assigned trans ontyric acid, probably via -elimination (E1cB) of the
C-terminal carboxylate. the basis of the vicinal coupling constant between the
H2 and H3 protons of the epoxide (3JHH  2.0 Hz), whichThe presence of the phosphohydroxyasparagine (po-
sition 9) in CDA2a was confirmed by 31P NMR (P  1.28 is in close agreement with the coupling constant ob-
served for ethyl 2,3-epoxyhexanoate [3JHH  1.9 Hzppm in DMSOd6). Chemical derivatization and sequenc-
ing by mass spectrometry is complicated by the phos- (trans) and 4.7 Hz (cis)] [17].
In summary, two previously uncharacterized peptides,phoryl group and so further structural studies on CDA2a
were carried out using NMR spectroscopy. Accordingly, CDA2a and CDA4a, which are produced by S. coelicolor
2377 in only very minor quantities in liquid culture, arethe majority of 1H and 13C chemical shifts for CDA2a
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Figure 3. Organization of the CDA Biosynthetic Gene Cluster
aNRPS-encoding genes; bgenes predicted to be involved in the biosynthesis of amino acid precursors or the amino acid tailoring enzymes;
cgenes proposed to be involved in the biosynthesis of the epoxyhexanoyl fatty acid side chain; dputative resistance genes; eputative regulation
genes; fthose genes which exhibit little or no similarity to genes of known function, or exhibit similarity with genes of known function but have
no obvious role in CDA biosynthesis, resistance, or regulation.
in fact the major metabolites produced by this strain genes exist beyond these boundaries that might be in-
volved in regulation, resistance, or transport of CDAwhen cultivated on solid medium (ONA). The structures
of these metabolites, which were determined using UV, from the cell has been considered [19] and cannot be
excluded at this stage. It is, however, notable that aNMR, and mass spectrometry, differ from the b-series
of CDA [9] by the presence of an unusual Z-2,3-dehyro- recent global microarray-based study of gene expres-
sion identified the genes SCO3210-3249 as a specifictryptophan residue rather than L-tryptophan at the C
terminus. Few nonribosomal peptides have been re- cluster that is upregulated during the transition to CDA
production [20]; this would fit the boundaries inferredported that contain Trp [14, 16]. On the basis of this
work, the structure of CDA3a (1480 Da) [9] can also be here on the basis of predicted function.
assigned (Figure 1). Thus, seven CDA variants have been
isolated so far. The most structurally modified peptide,
Biosynthetic Origins of CDA PrecursorCDA2a, probably constitutes the ultimate product of the
Building BlocksCDA biosynthetic pathway.
Adjacent to SCO3249, encoding the ACP homolog, are
genes encoding -ketoacyl-ACP synthase (KAS)-II and
-III homologs (SCO3248 and SCO3246), respectively.Organization of the CDA Gene Cluster
The chromosomal location of the CDA gene cluster was KAS-III is likely to catalyze the first condensation reac-
tion of acetyl and malonyl units, resulting in acetoacetyl-first identified using degenerate probes against known
conserved motifs of nonribosomal peptide synthetases ACP, while KAS-II is likely to catalyze the second con-
densation reaction to give -ketohexanoyl-ACP. Genes(NRPSs) [8]. Targeted disruption of the putative NRPSs
demonstrated their role in CDA biosynthesis. Regions encoding the other FAS enzymes, acetyl and malonyl
transacylases, -ketoacyl reductase, -hydroxyacyl de-within the CDA cluster were sequenced at UMIST, after
which the entire cluster and indeed the whole genome hydratase, as well as an enoyl reductase [21] are absent
from the cluster. Presumably, these enzymes are re-were sequenced at the Sanger Institute (Cambridge, UK)
[1]. The 82 kb CDA cluster (Figure 3) is located within cruited from primary metabolism and are responsible
for the synthesis of the fatty acid side chain precursor,the “core” region of the linear chromosome and consists
of at least 40 ORFs. The cluster is contained on the hexanoyl-ACP 1 (Figure 4A). hxcO (SCO3247) encodes a
protein similar to many acyl-CoA oxidases, which utilizeoverlapping cosmids ScE8-ScE63-ScE29 (SCO3210-
3249) [18]. Using the publicly accessible sequence annota- flavin adenine dinucleotide (FAD) in the desaturation of
acyl-CoAs to trans-enoyl-CoAs during fatty acid degra-tion (http://www.sanger.ac.uk/Projects/S_coelicolor/) and
the results of more detailed similarity searches (see Ex- dation [21]. This suggests that hexanoyl-ACP 1 is first
hydrolyzed to hexanoic acid, transformed to hexanoyl-perimental Procedures) performed on the deduced pro-
tein sequences encoded by each ORF, putative func- CoA 2, which is then desaturated by the hxcO gene
product, hexanoyl-CoA oxidase (HxcO), to give trans-tions of the gene products are suggested (Table 1). From
this, and taking into account the structure of CDA, a hexenoyl-CoA 3. This would necessitate the involvement
of a FAS thioesterase (TE) and acyl-CoA synthetasehypothesis for the mode of CDA biosynthesis is pro-
posed. At the boundaries of the cluster are genes encod- (ACS) [21], both of which may be recruited from primary
metabolism.ing DAHP synthetase (SCO3210) and acyl carrier protein
(ACP) (SCO3249) homologs. The possibility that other In close proximity, hcmO encodes a protein with typi-
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Table 1. Predicted Function of the Gene Products in the CDA Biosynthetic Cluster
ORF No. Gene Symbol Amino Acids Highest Protein Sequence Similarity1 Putative Function in CDA Biosynthesis
SCO3210 484 Dhs1 Arabidopsis thaliana class-II DAHP synthetase2
SCO3211 trpC2 258 TrpC Pseudomonas aeruginosa indole-3-glycerol phosphate synthase3
SCO3212 trpD2 335 TrpD Azospirillum brasilense anthranilate phosphoribosyltransferase3
SCO3213 trpG 200 TrpG Rhodobacter sphaeroides anthranilate synthase component II
SCO3214 trpE2 511 TrpE Pseudomonas putida anthranilate synthase component I3
SCO3215 glmT 338 PAB0269 Pyrococcus abyssi glutamate-3-methyltransferase
SCO3216 796 CtpE Mycobacterium tuberculosis H37Rv cation-transporting ATPase
SCO3217 cdaR 638 AfsR S. coelicolor transcriptional activator/regulatory protein4
SCO3218 71 MbtH M. tuberculosis CDC1551 unknown (NRPS-associated protein)5
SCO3219 391 platelet activating factor Cavia porcellus lipase
SCO3220 142 Sc8D11.8c encoded protein S. coelicolor unknown
SCO3221 284 NovF Streptomyces spheroides prephenate dehydrogenase
SCO3222 151 TbSP1 Tuber borchii Ca2 dependent phospholipase
SCO3223 264 ABC transporters S. coelicolor ABC transporter integral membrane protein
SCO3224 317 ABC transporters S. coelicolor ABC transporter ATP-binding protein
SCO3225 absA1 571 sensor kinase S. coelicolor sensor kinase absA1 [19]
SCO3226 absA2 222 response regulator S. coelicolor response regulator absA2 [19]
SCO3227 hpgT 431 HpgT Streptomyces lavendulae 4-hydroxyphenylglycine aminotransferase
SCO3228 hmo 377 Hmo Amycolatopsis orientalis 4-hydroxymandelate oxidase
SCO3229 hmaS 371 HmaS A. orientalis 4-hydroxymandelate synthase
SCO3230 cdaPS1 7463 multiple domains CDA peptide synthetase I
SCO3231 cdaPS2 3670 multiple domains CDA peptide synthetase II
SCO3232 cdaPS3 2417 multiple domains CDA peptide synthetase III
SCO3233 272 PCZA361.30 A. orientalis hydrolase/external thioesterase
SCO3234 hasP 300 SpcN S. flavopersicus phosphotransferase
SCO3235 615 ABC transporter S. avermitilis ABC transporter
SCO3236 asnO 333 Cas 1&2 Streptomyces clavuligerus asparagine oxygenase
SCO3237 462 Sc3F9.14 encoded protein phosphodiesterase6
SCO3238 386 Sc3F9.13 encoded protein unknown6
SCO3239 289 Sc3F9.12 encoded protein unknown6
SCO3240 236 Sc3F9.11 encoded protein unknown6
SCO3241 290 Hyi Sinorhizobium meliloti isomerase6,7
SCO3242 291 BchG Chlorobium tepidum prenyltransferase6,8
SCO3243 388 Ino1 Archaeoglobus fulgidus myo-inositol phosphate synthase6,9
SCO3244 265 none unknown
SCO3245 hcmO 420 NahW Pseudomonas stutzeri hexenoyl-CoA Monooxygenase
SCO3246 fabH4 330 mmyC Streptomyces coelicolor -ketoacyl-ACP synthase III
SCO3247 hxcO 600 ACX2 Arabidopsis thaliana hexanoyl-CoA oxidase
SCO3248 fabF3 406 FabF Aquifex aeolicus -ketoacyl-ACP synthase II
SCO3249 81 NMB1696 Neisseria meningitielis acyl carrier protein
1 Proteins with high sequence similarity to deduced proteins, whose function is either unknown or has not been considered within the literature
are not included.
2 DAHP, 2-keto-3-deoxy-D-arabinoheptulosonate-7-phosphate.
3 TrpC, D, and E paralogs are also encoded elsewhere in the genome [1].
4 A.E. Hayes, P.P. Chong, Z.H., F.F., and C.P.S., unpublished data.
5 Small highly conserved protein located within many NRPS-encoding biosynthetic gene clusters.
6 These ORFs show very high similarity, even at the DNA sequence level, to seven genes in identical order elsewhere on the S. coelicolor
genome (SCO6579-6573), but no clear role in CDA biosynthesis, resistance, or regulation can be proposed at this stage. Five of the gene
products (encoded by ORFs SCO3237-3240 and SCO3242) display high similarity with proteins derived from genes clustered together in
Nostoc species.
7 Moderately similar to other isomerases, especially hydroxypyruvate isomerase in Sinorhizobium meliloti.
8 Shows good alignment to the UniA prenyltransferase family and chlorophyll synthases.
9 Similar to several putative myoinositol phosphate synthases from marine and parasitic organisms.
cal FAD binding motifs and sequence similarity to the peroxyflavin intermediate 4, followed by elimination of
flavin-C4a-hydroxide (FADH-OH). A similar mechanismflavin-dependent monooxygenases, particularly salicy-
late hydroxylase and zeaxanthin epoxidase [22]. It is has been proposed for the Baeyer-Villiger type oxidation
of cyclic ketones catalyzed by FAD-dependent cyclo-anticipated that hcmO encodes a trans-hexenoyl-CoA
monooxygenase (HcmO) and is responsible for epoxida- hexanone monooxygenase [24]. Given that the epoxide
in CDA is trans, as evidenced by the magnitude of thetion of the enone 3. It is proposed that the distal oxygen
of flavin-C4a-hydroperoxide (FADH-OOH) functions as 3JHH coupling constant across the oxirane ring, the epoxi-
dation reaction is expected to occur with syn-stereo-an electrophile in the aromatic hydroxylases, resulting
in hydroxylation of phenolic substrates [23]. However, chemistry, resulting in a trans-2,3-epoxyhexanoyl-CoA
5. The possibility that enzyme-bound hexanoyl-ACP 1the enone substrate 3 is more likely to undergo conju-
gate addition by the nucleophilic distal oxygen atom of and trans-hexenoyl-ACP function as substrates for the
putative oxidase (HxcO) and monooxygenase (HcmO),flavin-C4a-peroxide (FADH-OO), resulting in an enol-
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Figure 4. Proposed Biosynthesis of CDA
(A) Biosynthesis of trans-2,3-epoxyhexanoyl-CoA. TE, thioesterase; ACS, acyl-CoA synthetase; HxcO, hexanoyl-CoA oxidase; HcmO, trans-
hexenoyl-CoA monooxygenase; FADH-OO, flavin-C4a-peroxide; FADH-OH, flavin-C4a-hydroxide.
(B) Biosynthesis of nonproteinogenic amino acids. HmaS, 4-hydroxymandelate synthase; Hmo, 4-hydroxymandelate oxidase; HpgT,
4-hydroxyphenylglycine transaminase; GlmT, glutamate-3-methyltransferase.
(C) Nonribosomal peptide synthetases and tailoring enzymes. C, condensation domain; A, adenylation domain; T, peptidyl carrier protein or
thiolation domain; E, epimerization domain; AsnO, asparagine oxygenase; HasP, 3-hydroxyasparagine phosphotransferase; TrpO, tryptophan
oxidase.
respectively, resulting in trans-2,3-epoxyhexanoyl-ACP, ilate to Trp the organism needs to rely on the trpA,B
genes of primary metabolism [1]. There are also threeseems less plausible. First, the putative oxidase shows
high similarity with many acyl-CoA oxidases and lower genes, hmaS, hmo, and hpgT, that display similarity to
ORFs from the vancomycin-type antibiotic biosyntheticsimilarity to acyl-CoA dehydrogenases, both classes of
enzyme turn-over acyl-CoA, not acyl-ACP substrates. gene clusters in Amycolatopsis orientalis [25] and Strep-
tomyces lavendulae [26]. These gene products haveSecond, an intermediate hexenoyl-ACP is likely to be
formed by the FAS -hydroxyacyl dehydratase, and thus been shown to be involved in the biosynthesis of L-4-
hydroxyphenylglycine (L-HPG) 9 [27, 28]. HmaS cata-direct epoxidation of this intermediate would bypass the
need for an oxidase activity in the first place. lyzes the oxidative decarboxylation of 4-hydroxyphe-
nylpyruvate 6 to give L-4-hydroxymandelic acid 7, whichIn addition to the first enzyme of the shikimate path-
way, DAHP-synthase encoded by SCO3210, there exists is oxidixed by Hmo to give 4-hydroxyphenylglyoxylate
8. Finally, transamination by HpgT gives L-HPG 9 (Fig-a second gene (SCO3221) that encodes a prephenate
dehydrogenase, which is another enzyme of the shiki- ure 4B).
mate pathway. Both are likely to be involved in the sup-
ply of precursors for the biosynthesis of the aromatic Nonribosomal Peptide Synthetases
and Tailoring Enzymesamino acids. In the case of tryptophan, there are four
other genes (SCO3211–3214) which encode enzymes At the center of the CDA gene cluster are three large
genes (cdaPS1–3) encoding nonribosomal peptide syn-TrpC2, D2, G, and E2. Interestingly, there are no trypto-
phan synthase-encoding genes (trpA and trpB) within thetase (NRPS) enzymes CdaPS1, 2, and 3. The peptide
synthetases have a typical modular organization [7] withthe cluster, so that to convert the local supply of anthran-
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repeating condensation (C), adenylation (A), and pepti- known to possess this function [15], a candidate TrpO-
encoding ORF has not been identified at present withindyl carrier protein or thiolation (T) domains (Figure 4C).
Additional epimerization domains (E) are also located the CDA cluster. The possibility that the tailoring en-
zymes modify the Trp and Asn residues, as phospho-at the end of modules 3, 6, and 9 that are responsible
for the D-configuration of the amino acid residues in the pantetheinyl-thioesters, while attached to their respec-
tive adenylation domains cannot be ruled out at thiscorresponding positions in CDA. The N-terminal se-
quence of CdaPS1 to the first conserved motif of the stage [36].
module 1 A domain (495 aa) shows little similarity with
NRPS domains of known function. It is postulated here Deletion of hmaS, the Hydroxymandelic Acid
Synthase-Encoding Genethat this sequence constitutes a domain (C	) that is in-
volved in the transfer of the trans-2,3-epoxyhexanoyl- There has been considerable effort to develop methods
that will allow for the engineered and possibly evenCoA moiety to the first amino acid (Ser) attached to
the thiolation domain of module 1. By analogy with the the combinatorial biosynthesis of novel nonribosomal
peptides [3–6]. Notably, there has been significant prog-biosynthesis of the lipopeptide surfactin [29], it is antici-
pated that an additional acyl transferase might also be ress in delineating rules through which it is possible to
reprogram NRPSs by domain or module swaps and byrequired for the acylation, which is likely to be the first
step in the assembly of the peptide. active-site modification of adenylation domains in vitro.
Despite this, there have been relatively few examplesOn the whole, the sequence of the putative amino acid
binding pockets of each of the A domains of CdaPS1, 2, [37] where these approaches have been implemented
in vivo leading to novel nonribosomal peptides.and 3 correspond well with the sequences of A domains
from other NRPS that recognize the same amino acids CDA is a particularly good system for exploring in vivo
engineered biosynthesis because the host genome has[30, 31]. Noticeably, the A domain of module 10 is unlike
other glutamic-acid-activating domains, suggesting that been fully sequenced, methods for the manipulation of
the genome are well established, and the peptide back-L-3-methylglutamic acid (L-3-MeGlu) 10 (Figure 4B) is
the cognate substrate. Nevertheless, CDA with both Glu bone of CDA is not highly modified or crosslinked. Thus,
issues of precursor supply can be addressed, and singleand L-3-MeGlu at position 10 have been isolated. It is
possible that the A domain of module 10 has a broader amino acid changes might be readily introduced without
disruption of overall structure or activity of the antibiotic.substrate specificity with the ability to activate both
amino acids. Furthermore, SCO3215 encodes a protein In a first attempt to engineer the biosynthesis of new
CDA lipopeptides in vivo, a mutasynthesis approachwith a centrally positioned amino acid sequence (90
aa) that exhibits similarity to regions of putative methyl- [38] was adopted that focuses on modification of the
4-hydroxyphenylglycine residue. The strategy involvestransferases, including RapQ from the rapamycin bio-
synthetic gene cluster of Streptomyces hygroscopicus generation of a deletion of the putative 4-hydroxyman-
delate synthase-encoding gene hmaS to produce a mu-[32] and MitN from the mitomycin C biosynthetic gene
cluster of Streptomyces lavendulae [33]. It is speculated tant that would be deficient in L-HPG 9 and the precur-
sors 7 and 8 (Figure 4B) and therefore unable to producethat SCO3215, tentatively named glmT here, encodes a
glutamate-3-methyltransferase required for C3-methyl- CDA. It was anticipated that the feeding of precursor
mandelate, arylglyoxylate, and arylglycine analogs toation of glutamic acid prior to activation by the tenth A
domain. this mutant should result in the production of modified
CDA derivatives.The module 9 A domain is similar to other Asn-activat-
ing domains from different origins [30, 31]. Hence, it The hmaS, hmo, and hpgT genes putatively involved
in L-HPG biosynthesis are considered likely to compriseseems likely that oxidation and phosphorylation of Asn
at position 9 in CDA occurs after assembly of the cyclic a single operon (Figure 5A). Since hmaS is the promoter-
proximal gene, it was important to design an hmaS genepeptide (Figure 4C). This is consistent with the existence
of two genes, asnO and hasP, which show similarity disruption that should not interfere with transcription
and translation of the downstream hmo and hpgT genes.with known oxygenases and phosphotransferases, re-
spectively. The former exhibits high similarity with clava- Therefore, the bulk of the hmaS coding sequence (co-
dons 10–324) was deleted, and an in-frame stop codonminate synthase (Cas) 1 and 2, an Fe(II)/2-oxoglutarate
oxygenase that is known to catalyze the -hydroxylation (TAG) was inserted at hmaS codon position 10. In this
deletion, the terminal 47 codons of the hmaS gene willof the arginine side chain of a monocylic -lactam pre-
cursor of clavaminic acid [34]. It is therefore likely that not be translated; this was considered unlikely to cause
polarity because there is a 150 nucleotide untranslatedasnO encodes the required asparagine oxygenase
(AsnO). The hasP gene product exhibits moderate simi- sequence between the native stop codon of hmaS and
the start codon of the downstream hmo gene. An appro-larity with the spectinomycin phosphotransferase
(SpcN) [35], which is involved in the phosphorylation priate deletion construct was first made in E. coli using
standard methods (see Experimental Procedures) [39,of an aminoglycoside antibiotic as part of the host’s
self-resistance mechanism; hasP is therefore likely to 40] and used to generate a deletion of hmaS in S. coeli-
color (hmaS), as illustrated schematically in Figure 5A.encode the required 3-hydroxyasparagine phospho-
transferase and may also be involved in the CDA self- The deletion was generated in both S. coelicolor MT1110
[13] (six isolates) and 2377 [12] (two isolates). The ex-resistance mechanism. The discovery of the a-series
CDA, which possess C-terminal Z-2,3-dehydrotrypto- pected structure of the deletants was confirmed by PCR
using primers flanking the deletion site (data not shown)phan residues, calls for a third tailoring enzyme trypto-
phan oxidase (TrpO). Although enzymes exist that are and Southern analysis (Figure 5B).
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Figure 5. Deletion of the hmaS Gene in the cda Cluster of S. coelicolor
(A) Physical map of the hmaS-encoding region of the cda cluster. The 2.5 kb flanking sequence upstream of the hmaS gene, hmaS-1, was
generated by PCR from cosmid ScE63 [18], incorporating BglII and XbaI sites at the ends. The 2.4 kb hmaS-2 flanking sequence was isolated
as a PstI-BglII fragment from cosmid 6E4 [8]. The resulting plasmid, pZMH3, was used to delete the hmaS coding sequence by double-
crossover gene replacement.
(B) Southern analysis. Chromosomal DNA from wild-type and selected hmaS isolates was digested with PstI, and the Southern blot was
probed with the 4.9 kb insert from from pZMH3 (random prime labeled with -32P-dCTP). The 2.4 kb and 2.5 kb PstI fragments of the wild-
type are replaced by a 3.9 kb fragment in the hmaS isolates. Lane 1, S. coelicolor 2377hmaS; lane 2, 2377 wild-type; lane 3, S. coelicolor
MT1110 wild-type; lanes 4 and 5, MT1110hmaS isolates; lane 6, end-labeled HindIII-digested  DNA size markers. The sizes of relevant
fragments are indicated (in kb). Other hybridizing fragments on the blot represent partial digestion products.
Mutasynthesis of CDAs Possessing Modified the mutants and screened for the production of novel
CDA derivatives using, in the first instance, gradientArylglycine Residues
The hmaS mutants derived from both 2377 and plate bioassays. For example, 4-fluorophenylglyoxylate
15 results in calcium-dependent antibiosis, with the ef-MT1110 were shown not to exhibit calcium-dependent
antibiosis using standard plate bioassays [8]. LC-MS fect increasing with substrate concentration (Figure 6A).
Conversely, the 4-chlorophenylglyoxylate fails to restoreanalysis of extracts derived from both mutant strains
grown on solid and in liquid media also revealed a clear antibiosis. Each substrate analog was then fed to liquid
cultures of the 2377hmaS mutant, and the productionabsence of any CDA metabolites of characteristic mo-
lecular weight and HPLC retention times. However, both of novel CDAs was determined using LC-MS. In the case
of the dehydroxy precursors (11–13), the major product,hmaS mutant strains, when grown in the presence of
racemic 4-hydroxymandelic acid 7, produced clear cal- with typical CDA retention times on RP-HPLC, exhibits
a molecular weight of 1560 Da, which is 16 Da down oncium-dependent zones of inhibition, which increased in
size across a gradient plate bioassay with 0 to 400 
g/ CDA2b. This is consistent with the existence of a novel
peptide CDA2d (Figure 1) possessing a phenylglycinemL1 of 7 (Figure 6A). The 2377hmaS mutant was also
grown in liquid media supplemented with either racemic residue, presumably D-configured, at position 6 rather
than D-HPG. Similarly, the fluorinated precursors 15 and4-hydroxymandelate 7, 4-hydroxyphenylglyoxylate 8, or
L-HPG 9 (25–200 
gmL1). In all cases, LC-MS analysis 16, as was predicted from bioassays, gave rise to a new
peptide of molecular weight 1578 Da (2 Da up) whichof the extracts clearly indicates the production of CDA2b
as the major product (Figure 6B). These results indicate is consistent with the structure CDA2fb possessing a
4-fluorophenylglycine residue (Figure 1). In contrast,that the deletion of hmaS did not interfere with expres-
sion of the adjacent downstream hmo and hpgT genes. none of the para-chloro 17–19 or para-methoxy 20–22
analogs gave rise to detectable CDA by LC-MS analysis.Large-scale fermentation of this mutant when supple-
mented with L-HPG allowed sufficient quantities of Presumably, increase in the size of the para-substituent
results in failure of the A domain to recognize and acti-CDA2b to be isolated for characterization by NMR. The
NMR data obtained (see Supplemental Data) were gen- vate the modified arylglycines.
It was also noted in these experiments that the aryl-erally in close agreement with that previously reported
[9], and HRESIMS (m/z 1577.5043 [MH], C67H82N14O29P glycines (13 and 16) resulted in the highest levels of
mutasynthesized derivatives (CDA2fb and 2d). There-requires 1577.5110) further confirms the structure as
CDA2b. As expected, the D-configured HPG enantiomer fore, separate large-scale fermentations of 2377hmaS,
supplemented with arylglycines 13 and 16, were carrieddid not re-establish CDA production in the hmaS mu-
tants, which is consistent with activation of L-HPG and out, and milligram quantities (2–5 mgL1) of the new
CDAs were isolated and purified by HPLC. The structureepimerization by the module 6 E domain.
A series of synthetic mandelate, arylglyoxylate, and of the peptides was confirmed using mass spectrometry
and NMR. First, HRESIMS of CDA2d (m/z 1561.5148arylglycine analogs (11–22) (Figure 6B) were also fed to
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Figure 6. Mutasynthesis of CDA with Modified Arylglycine Residues
(A) Typical gradient plate bioassay. MT1110 wild-type (w.t.) and MT1110hmaS mutants (two separate isolates) were grown on a concentration
gradient of between 0 to 400 
gmL1 of fluorophenylglyoxylate 15 in ONA supplemented with Ca(NO3)2. The plate was overlaid with an indicator
strain, typically Bacillus mycoides. The wild-type shows a uniform zone of inhibition, independent of the substrate concentration, while both
mutants show a zone of inhibition that is dependent on the concentration of substrate 15. In the absence of Ca2, no zones of inhibition are
observed (data not shown).
(B) The table shows the molecular weight of the most abundant CDA variant produced by the 2377hmaS mutant when supplemented with
natural precursors 7–9 and substrate analogs 11–22 in liquid media, as determined by LC-MS. Small amounts of other CDA derivatives were
also observed: aCDA1b (m.w.  1562) and CDA2a (m.w.  1574); bCDA (m.w.  1558) consistent with the structure CDA2d but containing a
single Trp residue; cCDA2fa (m.w.  1576) with a single Trp residue (Figure 1).
[MH], C67H82N14O28P requires 1561.5161) and CDA2fb [27, 28] also operates in S. coelicolor. Moreover, feeding
4-fluoro and 4-dehydroxy analogs of these precursors(m/z 1579.5017 [MH], C67H81N14O28FP requires
1579.5066) were consistent with the molecular formula to the hmaS mutant results in new CDA peptides with
modified arylglycines. In addition to generating new anti-for the structures proposed (Figure 1). In the case of
CDA2d, assignment of 1H and 13C chemical shifts for all biotics, the work presented here clearly indicates that
the enzyme Hmo, responsible for oxidation of 4-hydro-residues was possible with the aid of 1H-13C HMQC and
1H-1H COSY experiments (see Table 1 in the Supplemen- xymandelate 7, the transaminase HpgT, and the HPG-
activating A domain of module 6, do not require thetal Data). This reveals characteristic signals for the phe-
nylglycine residue [H/C  7.28/127.2 (4), 7.33/127.8 (3), para-hydroxyl group for substrate recognition and will
accommodate other para-substituents provided that7.41/126.7 (2)] that are clearly distinct from those of HPG
due to the absence of strong inductive and resonance they are no larger than the hydroxyl group. It can there-
fore be assumed that hydrogen bonding between theeffects of the para-hydroxyl substituent. Given that only
2 mg of pure CDA2fb was isolated, a complete assign- enzyme active sites and the phenolic-OH is not essential
for the turn-over of these enzymes.ment of all 1H and 13C shifts was not possible. However,
stronger signals in the aromatic region of the NMR spec-
trum did allow assignments of the key fluorophenylglyc- Significance
ine residue, and the presence of fluorine could clearly
be detected by the characteristic magnitude of the 1H-19F From the numerous microbial genome sequencing
projects, it has become apparent that there is a wealthcoupling constants [H/C  7.13 (3JHF 8.5 Hz)/114.5 (3),
7.48 (4JHF 4.5 Hz)/128.9 (2)]. Further confirmation of the of unidentified secondary metabolites and biosyn-
thetic machinery that might be utilized in an attemptpresence of a fluorophenylglycine residue in CDA2fb
was obtained through 19F{1H}-NMR (see Supplemental to generate new therapeutic agents, particularly anti-
biotics. This paper describes the isolation and charac-Data), which shows a singlet (F 114.7) that is typical
for fluorophenylglycine [41]. During the isolation of terization of two new acidic lipopeptides of the cal-
cium-dependent antibiotic (CDA) group from wild-typeCDA2fb, a minor amount (0.1 mg) of another muta-
synthesized peptide was isolated which exhibited m/z S. coelicolor. The structures differ from other CDAs by
the presence of a C-terminal Z-2,3-dehydrotrypothan1577.4878 ([MH], C67H79N14O28FP requires 1577.4910).
This is presumably Trp-containing variant CDA2fa residue, a rare nonproteinogenic amino acid that has
been found in only a few other nonribosomal peptide(Figure 1).
In conclusion, deletion of the hmaS gene abolished natural products to date.
Sequence analysis of the CDA gene cluster enabledCDA production in S. coelicolor. Feeding the mutant
4-hydroxymandelate 7, 4-hydroxyphenylglyoxylate 8, or a hypothesis that accounts for the biosynthesis of CDA
to be proposed. On the basis of this hypothesis, experi-L-HPG 9 re-establishes the production of CDA. This
clearly demonstrates that, as expected, the pathway ments can be designed to characterize the individual
enzymes proposed to be involved in the biosynthesisresponsible for the biosynthesis L-HPG in A. orientalis
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major peaks (retention times: 12.5 and 21 min) were collected andof CDA. A number of these enzymes are likely to dem-
concentrated in vacuo. To remove inorganic salts, the fractions wereonstrate novel activities that might be utilized in the
dissolved in H2O and passed through Varian C-18 Megabondelutemodification of other valuable peptide natural prod-
SPE cartridges (200 mg). The cartridges were then washed with
ucts. The sequence analysis was also utilized to design water (3 ml) and eluted with MeOH (3 ml). The MeOH eluant was then
experiments that have led to the first rational engi- evaporated in vacuo to give CDA2a (3.8 mg) and CDA4a (10.5 mg).
neered biosynthesis of acidic lipopeptides antibiotics
Derivatization of CDA4aof this class. This is significant given that the acidic
CDA4a was derivatized according to the method of Kempter etlipopeptide antibiotics, particularly the structurally re-
al. [9] using 1-propylamine instead of 2-propylamine. Accordingly,lated daptomycin, show significant potential as new
CDA4a (2.0 mg) was dissolved in DMF (200 
l) and acetonitrile
antimicrobial agents. (5 ml). To this solution was added 2-(1H-benzotriazole-1-yl)-1,1,3,3-
The mutasynthesis strategy that was adopted to tetramethyluronium tetrafluoroborate (TBTU) (25.0 mg, 77.9 
mol),




mol). The reaction was stirred at room temper-of the hydroxyphenylglycine (HPG) residue in CDA.
ature and monitored by LC-MS. After 6 hr, the reaction mixture wasHPG is a nonproteinogenic amino acid that is found
evaporated under reduced pressure and purified by semipreparativein a number of nonribosomal peptide natural products,
HPLC. The resulting CDA4a tetra-n-propylamide (0.3 mg) was dis-
including vancomycin. Thus, this strategy may also be solved in 1 M aq. NaOH (1 ml) and stirred at room temperature for
utilized to modify other important antibiotics. Alterna- 2 hr. H2O (10 ml) was then added to the reaction mixture, which was
tively, the methodology developed could be utilized cooled to 0C, adjusted to pH 2 with 0.5M aq. HCl, and then passed
through a Varian C-18 Megabondelute SPE cartridge (100 mg). Theto probe the later steps in the biosynthesis of HPG-
cartridge was washed with H2O (1 ml) and eluted with MeOH (1 ml).containing peptides, such as the timing of phenolic
The eluant was evaporated under reduced pressure to give CDA4acrosslinking and glycosylation events in the biosynthe-
tetra-n-propylamide linear peptide (Figure 2), which was sequenced
sis of the vancomycin group of antibiotics. by ESI MS-MS.
Experimental Procedures Characterization of CDAs
1D 1H, 31P, and 2D NMR spectra were recorded on a Bruker AMX500
Cultivation and Extraction of CDA2a and CDA4a or AV500 spectrometer fitted with a Nalorac 3 mm inverse broad
The S. coelicolor cda strain 2377 [12] is Act and is commonly band probe with z gradients. Standard Bruker pulse sequences were
used for studies on CDA production [8]. An agar plug of the S. used. Elevated temperatures were used in order to obtain spectra
coelicolor 2377 was used to inoculate 50 ml of SV2 seed medium sharp enough for interpretation. The signals were referenced to
in a 250 ml conical flask containing two 6 mm diameter glass beads. residual CD3SOCD2H at 2.52  and 39.5  for 1H and 13C, respectively.
This was incubated for 3 days at 28C and 250 rpm. This culture 1D 19F NMR spectra were recorded on a Bruker AV400 spectrometer
was used to inoculate 100 petri dishes, each containing 30 ml of fitted with a 5 mm QNP probe with z gradients. The signals were
oxoid nutrient agar (ONA) (0.1 ml of culture was spread over the referenced to CFCl3 at 0.0 .
surface of each plate). After 7 days incubation at 28C, the plates Electrospray ionization mass spectrometry was performed on a
were frozen overnight at 20C and then allowed to thaw at room Micromass Q-Tof 2. The electrospray capillary voltage was 3.4 kV
temperature. The freeze-thaw exudate from these plates (1.5 l) and cone voltage was 36V. The source temperature was maintained
was collected by filtration, acidified to pH 2 with 0.5 M aq. HCl, and at 100C. Mass measurements were performed at a resolution of
adsorbed onto Varian C-18 Megabondelute SPE cartridges (10 g). 10,000 RP, and ESI MS-MS studies were performed at a resolution
The cartridges were washed with H2O (50 ml) and eluted with MeOH of 5000 RP.
(50 ml). The MeOH eluant was concentrated to dryness in vacuo.
SV2 contained, per liter: glucose, 15 g; glycerol, 15 g; soy peptone, Sequence Similarity Searches
15 g; NaCl, 3 g; CaCO3, 1 g. The medium was adjusted to pH 7.0 Standard protein-protein BLAST searches on the NCBI database
before sterilization. were inspected to identify proteins similar to those found within the
CDA cluster. The default settings, excluding the low-complexity
Bioassay Guided Fractionation parameter, were used throughout. The putative function of genes
A 5 mgmL1 sample of this extract was prepared in DMSO. An aliquot within the cluster was deduced according to the similarity score with
(100 
l) was fractionated by analytical HPLC using the following other known or consensus protein motifs, as well as the plausible
conditions: Hypersil Elite C-18, 3 
, 150  4.6 mm column; solvent influence of any conserved domains in determining a probable role
A was H2O with 0.1% HCO2H; solvent B was 90% acetonitrile in H2O in CDA biosynthesis and regulation. This analysis builds significantly
with 0.1% HCO2H. The flow rate was 1 mLmin1 with a gradient on the original annotation of the cda cluster (contained within EMBL
elution of 0% B increasing to 100% B over 30 min, then held at 100% accession number AL645882) and has led to the assignment of
B for 10 min. Fractions were collected every minute, concentrated to specific biochemical functions for a large number of the predicted
dryness in vacuo, redissolved in DMSO (50 
l), and subjected to proteins (Table 1).
bioassay using B. mycoides as the indicator in the presence and
absence of Ca2 [8]. Construction of pZMH3 and Deletion of hmaS
S. coelicolor MT1110 is a prototrophic SCP1, SCP2 derivative of
wild-type strain 1147 [13]. Unless stated otherwise, all methods andPurification of CDA2a and CDA4a
The crude extract (200 mg) from the exudate prepared as de- media used for growth and transformation of Streptomyces were
as described previously [42]. Streptomycete strains were grown inscribed above was dissolved in DMSO (2 ml) and H2O (20 ml). This
suspension was adsorbed onto a Varian Megabondelute C-18 SPE YEME liquid medium for preparation of protoplasts and for isolation
of chromosomal DNA. E. coli strains used in this study are as detailedcartridge (5 g). The cartridge was washed with H2O (5 ml) and eluted
with 30% acetonitrile in H2O (20 ml). The eluant was concentrated by Bucca et al. [39], and the standard methods used for DNA manip-
ulation are as described by Sambrook et al. [40]. A standard “double-to dryness in vacuo and dissolved in DMSO (2 ml). Purification was
achieved using preparative RP-HPLC on a Gilson Unipoint system crossover” replacement strategy was used to delete hmaS from the
chromosome [13] using the delivery plasmid pZMH3. In brief, pZMH3(2  1 ml injections) using the following conditions: Hypersil Elite
C18, 5 
, 150  20 mm column; solvent A was 25 mM aq. NH4OAc was generated by cloning two fragments that flank the chromosomal
sequence destined for deletion into the E. coli plasmid pMT3008 (awith 0.3% TFA; solvent B was 25 mM NH4OAc in 90% acetonitrile/
H2O with 0.3% TFA. The flow rate was 20 mLmin1 with an isocratic derivative of pMac containing the hyg resistance gene for selection
in Streptomyces). An “upstream” 2.5 kb flanking sequence desig-elution of 35% B in A; detection by UV at   280 nm. The two
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nated hmaS-1 was generated by PCR using cosmid ScE63 [18] as (C3/5), 125.3 (C1), 132.7 (C2/6), 164.9 (C4), 173.7 (CO2), 196.1 (Ar-
CO); m/z (ESI) 179 ([M–Na], 100%); HRMS m/z (ESI) 179.0347the template (EMBL accession number AL035640); primers hmasA1
(5	-GAAGATCTAATGAAGGAAGGGGAAAGG; including the nucleo- ([M–Na], C9H7O4 requires m/z 179.0344).
tide coordinates 2506–2524 and incorporating a BglII site) and
hmasA2 (5	-GCTCTAGAACTCCCACACGGACAC; including the nu- Mutasynthesis of CDA
The restoration of calcium-dependent antibiosis in the hmaS mu-cleotides 4818–4836 [complement], and incorporating a XbaI site)
were used to amplify hmaS-1 using standard conditions. The tants by the exogenous supply of 4-hydroxyphenylglycine 9, precur-
sors 7 and 8, and analogs 11–22 was screened using gradient plate“downstream” 2.4 kb flanking sequence, designated hmaS-2, was
isolated as a PstI-BglII restriction fragment from cosmid 6E4 [8]; bioassay as follows: ONA (160 ml) supplemented with substrate
(400 
gmL1) was poured into square petri dishes (23  23 cm)the BglII site corresponds to nucleotide coordinates 1555–1560 of
cosmid ScE63. The location of these fragments relative to the cda held on an incline. After setting, the plates were placed horizontally,
and an equal volume of nonsupplemented ONA was poured ontocluster is shown in Figure 5A. Nonmethylated plasmid pZMH3 was
the plates. Plates were inoculated with single 50 
l streaks ofNaOH denatured [39] and used to transform S. coelicolor 2377 and
S. coelicolor strains 2377 and 2377hmaS or MT1110 andMT1110 protoplasts. Hygromycin-resistant transformants were iso-
MT1110hmaS from 3-day SV2 seed cultures prepared as describedlated and passaged through two rounds of sporulation on nonselec-
above. The plates were incubated for 3 days, then overlaid with softtive media. Hygromycin-sensitive double-crossover recombinants
ONA (100 ml) containing Bacillus mycoides and Ca2NO3 to give a finalwere isolated, and the desired hmaS deletion derivatives were iden-
concentration of 12 mM Ca2 as described previously [8]. Duplicatetified by PCR and Southern analysis of genomic DNA (Figure 5B).
plates were similarly prepared but with no Ca2.
Small-scale liquid feeding experiments were carried out in 7 mlSynthesis of Precursors and Analogs for Mutasynthesis
of SM22 media innoculated with 300 
l of 2377hmaS from a 3-day4-hydroxyphenylglyoxylic acid 8 was prepared by the oxidation of
SV2 seed culture. SM22 contained, per liter: monosodium glutamate,4-hydroxyacetophenone [43]. para-substituted arylglyoxylates 15,
18.7 g; NaCl, 0.5 g; K2HPO4, 0.5 g; 3-(N-morpholino)propane-sul-18, and 21 were prepared from the corresponding ethyl esters, which
phonic acid (MOPS), 21.0 g; lactose, 30.0 g; *0.2 M MgSO4, 10were synthesized using Friedel-Crafts acylation reactions [44]. Ra-
ml; *0.02 M CaCl2, 10 ml; *1 M H2SO4, 5 
l; *ZnSO4.7H2O, 4.3 mg;cemic 4-chlorophenylglycine and 4-methoxyphenylglycine were do-
*MnSO4.7H2O, 1.115 mg; *H3BO3, 0.31 mg; CuSO4.5H2O, 0.625 mg;nated by GlaxoSmithKline. Other substrates were purchased from
*NaMoO4.2H2O, 0.24 mg; *CoCl2.6H2O, 0.24 mg; *FeSO4.7H2O, 9 mg;Sigma or Fluka.
*KI, 0.415 mg. The S. coelicolor strain 2377 is a histidine and uracil
4-Hydroxyphenylglyoxylic Acid 8
auxotroph; therefore, the media was also supplemented with histi-
mp 140C (slow decomposition); max (Nujol)/cm1 2926 (Ar-CH), 1658 dine (50 
gmL1) and uracil (7.5 
gmL1). Ingredients indicated with
(ketone CO), 1608 (CO2), 1370 (CO2); max (H2O)/nm 250 (/dm3 an asterisk were added in order, and the medium was adjusted to
mol1 cm1 12685); H (400 MHz, DMSO-d6) 6.95 (2H, d, J 9.0 Hz, pH 7.0 prior to sterilization. The cultures were then incubated at
H3/5), 7.82 (2H, d, J 9.0 Hz, H2/6); C (75.5 MHz, DMSO-d6) 116.4 28C, 250 rpm, for 2 days. Filter-sterilized aqueous solutions of
(C3/5), 123.6 (C1), 132.6 (C2/6), 164.2 (C4), 167.2 (CO2), 187.4 (Ar- precursors 7–22 (5 mgmL1) were then added to give final concentra-
CO); m/z (ESI) 165 ([M–H], 100%); HRMS m/z (ESI) 165.0188 tions of 25 
gmL1, 50 
gmL1, 100 
gmL1, and 200 
gmL1.
([M-H], C8H5O4 requires m/z 165.0188). After a total of 6 days incubation, the cultures were harvested by
Sodium 4-Chlorophenylglyoxylate 18 centrifugation, and the supernatants were adjusted to pH 2.0, ex-
Aluminium chloride (1.39 g, 10.4 mmol) was added to a mixture of tracted on Varian Megabondelute C-18 SPE cartridges (0.5 g), eluted
chlorobenzene (0.51 ml, 5.0 mmol) and ethyl oxalyl chloride (0.82 with MeOH (2 ml), and evaporated in vacuo. Extracts were then
ml, 7.3 mmol) in dichloromethane (10 ml) and stirred for 8 hr at analyzed by LC-MS using an LCQ DuO mass spectrometer in elec-
between 10C–0C. The reaction mixture was warmed to room trospray ionisation mode with positive/negative ion switching and
temperature, crushed ice (29 g) in concentrated aq. HCl (19 ml) was the following LC conditions: Hypersil Elite C18, 3 
, 150  4.6 mm
added, and the separated organic layer was washed with 0.1 M aq. column; solvent A was 10 mM aq. NH4Oac with 0.1% HCO2H; solvent
NaOH (3 15 ml), dried over MgSO4, and evaporated under reduced B was 10 mM NH4OAc in 90% acetonitrile/H2O with 0.1% HCO2H.
pressure. Purification by flash column chromatography on silica gel The flow rate was 1 mLmin1 with a gradient of 2% B and 98% A,
eluting with hexane/ethyl acetate (6:1→5:1) gave ethyl 4-chlorophe- increasing to 100% B over 20 min, then held for 5 min.
nylglyoxylate (0.46 g) as a pale yellow oil. This was then dissolved Large-scale incubations were carried out in an analogous fashion
in THF (1 ml), and 2.2 M aq. NaOH (1 ml) was added in two portions. with 2377 hmaS in SM22 medium. One-liter cultures (20  50 ml
The reaction mixture was stirred for 30 min and evaporated under in 250 ml conical flasks) were fed the following precursors: L-4-
reduced pressure to give the title compound (0.41 g, 40%) as a hydroxyphenylglycine 9, (/) phenylglycine 13, and (/) 4-fluoro-
white crystalline solid, mp 230C (slow decomposition); max (Nujol)/ phenylglycine 16 to a final concentration of 100 
gmL1. CDAs were
cm1 2924 (Ar-CH), 1649 (ketone CO), 1598 (CO2), 1382 (CO2), 787 extracted and purified using preparative RP-HPLC on a Gilson Uni-
(p-Ar); max (MeOH)/nm 257 (/dm3 mol1 cm1 19074); H (300 MHz, point system (4  1 ml injections) using the conditions described
D2O) 7.45 (2H, m, H3/5), 7.78 (2H, m, H2/6); C (75.5 MHz, D2O) 129.7 above. This gave CDA2d (5 mg), CDA2fb (2 mg), and CDA2fa
(C3/5), 130.9 (C1), 131.5 (C2/6), 141.2 (C4), 172.8 (CO2), 196.1 (Ar- (0.1 mg)
CO); m/z (ESI) 183 ([M–Na], 100%), 110 ([M–COCO2Na], 10);
HRMS m/z (ESI) 182.9848 ([M-Na], C8H4ClO3 requires m/z Acknowledgments
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3JCF 9.5 Hz, C2/6), 166.9 (d, 1JCF 255.1 Hz, C4), 173.1 (CO2), 195.8 C.M. and L.G. Z.H. is the recipient of a PhD scholarship from Esfahan
(Ar-CO); m/z (ESI) 167 ([M–Na], 100%), 95 ([M–COCO2Na], 20); University (Iran) and the Iranian Ministry of Science, Research and
HRMS m/z (ESI) 167.0146 ([M–Na], C8H4FO3 requires m/z Technology. M.B. is the recipient of an Overseas Research Student
167.0145). (Universities, UK) award and a UMIST Graduate Research Scholar-
Sodium 4-Methoxyphenylglyoxylate 21 ship. M.B. gratefully acknowledges Mr. and Mrs. G.A. Borg for addi-
Similarly prepared from anisole: mp 300C (slow decomposition); tional financial support.
max (Nujol)/cm1 2923 (Ar-CH), 1641 (ketone CO), 1600 (CO2), 1389
(CO2), 810 (p-Ar); max (H2O)/nm 221 (/dm3 mol1 cm1 15401), 282 Received: July 30, 2002
(28795); H (300 MHz, D2O) 3.71 (3H, s, OCH3), 6.89 (2H, d, J 8.7Hz, Revised: September 12, 2002
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